Your browser doesn't support javascript.
loading
An Oncofetal Glycosaminoglycan Modification Provides Therapeutic Access to Cisplatin-resistant Bladder Cancer.
Seiler, Roland; Oo, Htoo Zarni; Tortora, Davide; Clausen, Thomas M; Wang, Chris K; Kumar, Gunjan; Pereira, Marina Ayres; Ørum-Madsen, Maj S; Agerbæk, Mette Ø; Gustavsson, Tobias; Nordmaj, Mie A; Rich, Jamie R; Lallous, Nada; Fazli, Ladan; Lee, Sherry S; Douglas, James; Todenhöfer, Tilman; Esfandnia, Shaghayegh; Battsogt, Dulguun; Babcook, John S; Al-Nakouzi, Nader; Crabb, Simon J; Moskalev, Igor; Kiss, Bernhard; Davicioni, Elai; Thalmann, George N; Rennie, Paul S; Black, Peter C; Salanti, Ali; Daugaard, Mads.
Afiliación
  • Seiler R; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Urology, University of Bern, Bern, Switzerland.
  • Oo HZ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Tortora D; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Clausen TM; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Cope
  • Wang CK; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Kumar G; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Pathology and Laboratory Medicine, University of British Columbia, Vancouver, BC, Canada.
  • Pereira MA; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
  • Ørum-Madsen MS; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Agerbæk MØ; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Cope
  • Gustavsson T; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
  • Nordmaj MA; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
  • Rich JR; Zymeworks Inc., Vancouver, BC, Canada.
  • Lallous N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Fazli L; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Lee SS; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Douglas J; Department of Urology, University Hospital of Southampton, Hampshire, UK.
  • Todenhöfer T; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Esfandnia S; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Battsogt D; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Babcook JS; Zymeworks Inc., Vancouver, BC, Canada.
  • Al-Nakouzi N; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Crabb SJ; Department of Medical Oncology, University Hospital of Southampton, Hampshire, UK.
  • Moskalev I; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Kiss B; Department of Urology, University of Bern, Bern, Switzerland.
  • Davicioni E; GenomeDx Biosciences, Inc., Vancouver, BC, Canada.
  • Thalmann GN; Department of Urology, University of Bern, Bern, Switzerland.
  • Rennie PS; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Black PC; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada.
  • Salanti A; Department of Immunology and Microbiology, Centre for Medical Parasitology, University of Copenhagen, Copenhagen, Denmark; Department of Infectious Diseases, Copenhagen University Hospital, Copenhagen, Denmark.
  • Daugaard M; Department of Urologic Sciences, University of British Columbia, Vancouver, BC, Canada; Vancouver Prostate Centre, Vancouver, BC, Canada; Zymeworks Inc., Vancouver, BC, Canada. Electronic address: mads.daugaard@ubc.ca.
Eur Urol ; 72(1): 142-150, 2017 07.
Article en En | MEDLINE | ID: mdl-28408175
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Sulfatos de Condroitina / Cisplatino / Resistencia a Antineoplásicos / Antígenos de Protozoos / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans País/Región como asunto: America do norte / Europa Idioma: En Año: 2017 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligopéptidos / Neoplasias de la Vejiga Urinaria / Biomarcadores de Tumor / Sulfatos de Condroitina / Cisplatino / Resistencia a Antineoplásicos / Antígenos de Protozoos / Antineoplásicos Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Animals / Humans País/Región como asunto: America do norte / Europa Idioma: En Año: 2017 Tipo del documento: Article